Background: Sepsis is a major cause of mortality with an estimated 37 000 UK deaths
Introduction
Sepsis is a major cause of mortality with an estimated 37 000 UK deaths each year (1) .
Death can occur at any age inside and outside of hospital. The presentation of sepsis can be non-specific and, the diagnosis may be delayed or even missed. A recent UK National Confidential Enquiry into Patient Outcome and Death (NCEPOD) concluded that there was a lack of urgency in the management of severe sepsis, with only 1 in 3 patients receiving good care (2). The principle recommendations were that hospitals and primary care should have formal sepsis protocols, staff trained in their use and that all septic patients should receive a bundle of interventions, with senior Microbiology advice available within 24 hours. In 2015, NHS England introduced a commissioning for quality and innovation (CQUIN) payment for those NHS trusts screening for sepsis, taking cultures and administrating empirical antibiotics within one hour (3) .
Because of delays in diagnosis and initiation of treatment, new sepsis definitions in 2015 were agreed to enable easier 'out of hospital' or bedside diagnosis (4). To optimise outcomes, a care bundle approach implemented within 1 hour is required (sepsis 6) (5) with further actions required within 6 hours if the patient is admitted to critical care. The National Institute of Clinical Excellence (NICE) recommends auditing outcomes in patients with severe sepsis or septic shock (6), not only to provide mortality data comparable to other institutions, but also to offer assurance that processes for managing sepsis are in place and working. literature, however, there is little data on additional host factors that predict sepsis severity at the time of presentation, other than altered mental state, hypotension and tachypnoea (7) . Early identification of factors that predict severe sepsis is important for inpatients that require management in critical care, but also for patients in the community seen before blood is taken and results made available. We, therefore, aimed to determine other patient factors that can predict severe sepsis by analysing data from a bacteraemic cohort at the Royal London Hospital (RLH) in East London.
Methods:

Study setting
The study was undertaken at the RLH, Barts Health NHS Trust. The RLH serves a diverse population of approximately 250 000 patients in Tower Hamlets, East London.
It is a regional referral centre for the North East London sector. In addition to Accident and Emergency, general medicine, surgery, paediatric and maternity services, the RLH has 60 high dependency and critical care beds, (including neurosurgical, renal and Obstetric and Gynaecological beds), specialist wards for renal transplant and haemodialysis patients, and a high level neonatal intensive care unit.
Study population
From December 2012 to November 2013, consecutive in-patients with bacteraemia and fungaemia were prospectively collected.
Definitions
Significant bacteraemia or fungaemia was defined as a blood culture isolate, unlikely to be an environmental or skin contaminant, ascertained from a patient with a compatible clinical syndrome. This decision was based on the patient's history, examination findings, response to antimicrobial treatment, blood culture isolate and bacterial cultures from other body sites. Community and hospital-acquired bacteraemia or fungaemia were defined as a positive blood culture obtained at least 48 hours before or after hospital admission respectively. Health-care associated infection (HCAI) was defined as an infection in a patient who had been hospitalised for more than 48 hours in the last 90 days or, in the 30 days before bacteraemia, resided in a nursing home or attended hospital for haemodialysis or intravenous therapy.
Specialities at the time of treatment were categorised as medicine, surgery, critical care, obstetrics and gynaecology and paediatrics.
Sites of infection associated with medical devices and procedures were defined according to the Centers for Disease Control and Prevention surveillance definitions (8) . For central venous catheter (CVC)-associated infection, this was defined as evidence of infection (erythema, induration or pus) at a CVC exit site or isolation of the same organism from the blood or line tip. Catheter-associated urinary tract infections (UTIs) were defined as infection in patients with indwelling urethral or suprapubic catheters, or patients who intermittently self-catheterised, in the presence of symptoms or signs compatible with a UTI where no other source was identified.
Other sites, not related to medical devices, were defined by clinical assessment, radiological imaging and additional bacterial cultures. Bacteraemia or fungaemia in patients with an unknown source were classified as undefined. Subsequent bacteraemic episodes were defined as an infection with the same organism occurring more than 28 days after the first episode, or a bacteraemic episode with a different organism occurring within 28 days.
Appropriate treatment was defined as any component of an antibiotic regimen, empiric or definitive, used to treat an infection to which the organism was susceptible 'in vitro'. Delay in treatment was measured from the time a significant blood culture was obtained from the patient (9) . This was irrespective of the onset of sepsis.
Data collection
Attending physicians were advised to obtain blood cultures from patients presenting with symptoms and signs suggestive of sepsis before administration of empirical antibiotics. Demographical, laboratory and clinical data were collected on all inpatients who developed bacteraemia. A consultant Microbiologist, aided by several specialist registrars, reviewed case notes within 72 h of laboratory confirmation. In addition to demographic data, speciality at the time of bacteraemia, site of infection, organism, susceptibility profile, delay in appropriate treatment, Pitt bacteraemia score, Charlson comorbidity index (CCI) score (10) and outcomes were recorded. The Pitt bacteraemia score is a validated index used in other studies to quantify severity of infection, based on mental status, need for ventilation and vital signs. Patients were followed up until inpatient death, discharge home, transfer to a rehabilitation ward or recovery from infection.
Patients were treated empirically according to local guidelines based on site of infection. Once susceptibility profiles were known, antibiotic treatment regimens were rationalised to narrow spectrum agents. Outcomes were recorded as 7-day, 30-day and inpatient mortality. It was assumed that patients who were discharged prior to 7 or 30 days survived beyond 30 days.
Microbiology data
Blood cultures were analysed using the automated system BacT/ALERT3D (bioMérieux, Mary l'Etoile, France). Isolates were identified using either the VITEK MS system (bioMérieux, Mary l'Etoile, France, database v2.0) or Bruker Biotyper (Bruker Daltonics, Leipzig, Germany, software version 3.0) MALDI-TOF MS systems according to the manufacturer's instructions and the laboratory standard operating procedures. Susceptibility testing was performed on the Microscan walkAway system (Siemans Healthcare Diagnostics, Deerfield, Il, US).
Data analysis
Data were split by bacteraemia episodes with Pitt bacteraemia scores less than 2, or greater than and equal to 2. Even though some patients had more than one episode, we summarised for all episodes because many of these patients' have episodes in both Pitt bacteraemia score categories. The data were presented as numbers with percentages and comparisons using Χ
Clinical governance
The clinical governance audit committee of Barts Health NHS Trust approved this study. Ethical approval was not required.
Results:
594 bacteraemic episodes occurred in 500 patients who were divided according to Pitt scores (table I). The majority of bacteraemic episodes occurred both in patients aged > 50, 382/594 (64.3%), and males, 346/594 (58.2%). Episodes were roughly distributed between community-acquired, health care associated and hospital-acquired infections. Community-acquired bacteraemia was not associated with severe sepsis (Pitt score greater than or equal to 2). The commonest bacteraemic isolates were Escherichia coli 207/594 (34.8%) and methicillin-sensitive Staphylococcus aureus 57/594 (9.6%). Patient speciality and site of infection, in particular critical care admission and catheter associated UTIs, were significantly associated with severity. Patient outcomes were significantly associated with severity and, in a subgroup of patients with a Pitt score greater than or equal to 2, mortality at 7-days was 6.0% (95% CI 3.0, 10.5) and inpatient mortality 8.7% (95% CI 5.1, 13.7) respectively.
Gram negative isolates were significantly associated with severe sepsis (table 1) . There were significant differences in susceptibility profiles (table II) . Co-amoxiclav resistance, meropenem resistance and ESBL production were significantly associated with severe sepsis. There was no association with aminoglycoside resistance.
Logistic regression analysis is summarised in table III. Site of infection was significantly associated with severe infection in multivariate analysis. In particular, this association was strongest for catheter associated UTI, (OR 3.87, 95% CIs 1.82, 8.22)
Discussion:
In a bacteraemic cohort, after adjustment for age, sex, CCI and where infection was acquired, we demonstrated that site of infection, in particular catheter associated UTIs, was associated with severe sepsis. This is an important finding as device related infections are potentially preventable.
The strength of this study was that the Pitt score (a severity index) was used as the primary outcome rather than mortality, although both are strongly associated. At presentation, confusion, haemodynamic instability and tachypnoea are included in new guidance for recognition of severe sepsis (7) . Uniquely, our data suggests that the presence of a urinary catheter is a predictor of severe sepsis and, therefore, at the earliest signs of sepsis, consideration should be given to immediate admission to hospital or, for inpatients, management in a critical care area.
Few studies have examined risk factors for severe sepsis in bacteraemic patients. In a Spanish cohort of community-onset bacteraemic UTIs from eight tertiary hospitals, risk factors associated with severe sepsis were fatal underlying disease, history of urinary obstruction and indwelling urinary catheters (11) . In multivariate logistic regression analysis, urinary catheterisation remained a significant risk factor for patients without fatal underlying disease. In patients with E. coli bacteraemia, associations with severe sepsis are variable. In a 12 month prospective cohort study in two French University hospitals, one paper describes no host determinants influencing severity of sepsis at presentation although bacterial and host determinants both influenced outcomes significantly (12) . In another prospective French multicentre cohort study involving 1051 patients from 14 University Hospitals, age, liver cirrhosis, hospitalisation before bacteraemia and portal of entry were significantly associated with mortality, although no mention was made of urinary catheters (13).
Our study is of particular relevance following NHS England's initiative to reduce E. coli bacteraemias (14) . An important part of this strategy is a reduction in urinary catheter associated bacteraemias, and our study suggests this is an important priority as not only are some of these infections preventable, but they are also associated with severe sepsis. Across the NHS there is a need for a systematic care bundle approach to urinary catheterisation (15), in particular documented reasons for insertion, anticipated date of removal and adherence to aseptic technique at insertion and during after-care. Patients with long term catheters should all receive catheter passports, community nurses should have access to guidance on the use of prophylactic antibiotics when changing catheters and some patients may benefit from suprapubic catheterisation, which is associated with less infection compared to urethral catheterisation (16) . Even so, if a 20% reduction in bacteraemic catheter associated UTIs was achieved (17) , this may not be sufficient in itself to achieve an overall 10% reduction in E. coli bacteraemias (18) for which a CQUIN payment will be available in 2016/17. However, this could have a significant impact on hospital admissions due to severe sepsis, including admission to critical care units.
There was an association between Gram-negative multiple drug resistance and severe sepsis. There is little in the literature to suggest that multiple drug resistant organisms are intrinsically more virulent, and it would appear more plausible that the association with severity was a consequence of delay in appropriate antibiotic administration due to unanticipated resistance (19) .
There were limitations to this study. A larger cohort may have identified other host risk factors associated with severe sepsis, although this study was sufficiently powered to demonstrate a strong association with urinary catheterisation. Our findings apply to a bacteraemic cohorts, and it is not clear whether they are applicable to other severe sepsis cohorts without bacteraemia.
We demonstrated that in the context of sepsis, the presence of a urinary catheter should prompt immediate referral to A&E, implementation of 'sepsis 6' and, for inpatients, consideration of transfer to a critical care unit to optimise management. It should also increase awareness that unless there is a good reason, urinary catheters should not be inserted, a care bundle approach should be used, and when they are inserted a removal date anticipated unless long term catheterisation is required. A standardised approach across all UK NHS trusts is likely to contribute to a reduction in the incidence of severe sepsis and E. coli bacteraemia, two key elements of NHS England's strategy to improve patient safety and better utilise hospital beds. Using generalised estimating equations to account for multiple bacteraemia episodes for some patients OR: odds ratio; CI: confidence interval; GI: gastro intestinal; HPB: hepato-pancreato-biliary; LRT: lower respiratory tract
